Cite
MLA Citation
Edward J Fox et al.. “Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial.” Multiple sclerosis, vol. 24, 2018, pp. 1862–1870. http://access.bl.uk/ark:/81055/vdc_100074434972.0x000de5